GlassScriptPhysician profile
Claudia Farrell
NPI 1740500222
$2,164.79
in general payments reported to CMS, 2019-2025
20 companies · $342 in 2025
The $342 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $154 · 2021: $171 · 2022: $318 · 2023: $510 · 2024: $559 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $478.86 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $370.18 | 2019-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $305.22 | 2019-2025 | |
| Corium, LLC | $265.14 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $113.79 | 2019-2025 | Bexsero, Penmenvy |
| Merck Sharp & Dohme LLC | $104.88 | 2020-2025 | Gardasil 9, Vaxelis, Gardasil |
| Sanofi-Aventis U.S. LLC | $71.90 | 2025 | |
| Collegium Pharmaceutical, INC. | $63.16 | 2025 | Jornay Pm |
| Seqirus USA INC | $59.29 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Sobi, INC | $55.00 | 2020-2023 | |
| Kaleo, INC. | $45.36 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.52 | 2020-2021 | |
| Novo Nordisk INC | $42.19 | 2023-2025 | Wegovy |
| Pfizer INC. | $31.00 | 2019-2023 | |
| Ars Pharmaceuticals Operations, INC. | $24.25 | 2025 | Neffy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $23.63 | 2023 | Aptima |
| Biomarin Pharmaceutical INC. | $21.69 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.01 | 2019 | |
| Abbvie INC. | $16.59 | 2020 | |
| Tris Pharma INC | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.